Drug Information

General Information
Drug ID
DR00248
Drug Name
Telmisartan
Synonyms
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C33H30N4O2
Canonical SMILES
CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
InChI
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
InChIKey
RMMXLENWKUUMAY-UHFFFAOYSA-N
CAS Number
CAS 144701-48-4
Pharmaceutical Properties Molecular Weight 514.6 Topological Polar Surface Area 72.9
Heavy Atom Count 39 Rotatable Bond Count 7
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 4
XLogP
6.9
PubChem CID
65999
PubChem SID
103271997 , 103974749 , 104253350 , 104335216 , 11372057 , 11374980 , 11485867 , 11489792 , 11490904 , 11493075 , 11528632 , 117546129 , 117867825 , 12014783 , 14860450 , 26612858 , 26680963 , 26719833 , 26749005 , 26749006 , 43122721 , 46386620 , 46505370 , 46530547 , 47350860 , 47796474 , 48416595 , 49648460 , 49830991 , 50107502 , 56312042 , 56313977 , 57315885 , 6866718 , 7847693 , 79018553 , 7980737 , 81041072 , 81092854 , 8190092 , 85209733 , 85789678 , 87225392 , 92124871 , 92308092 , 92308546 , 92309313 , 92712346 , 93166523 , 9912
ChEBI ID
ChEBI:9434
TTD Drug ID
D0N6RF
DT(s) Transporting This Drug OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [2]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [2]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OATP1B3 Transporter Info Km = 0.81 microM Human embryonic kidney cells (HEK293)-OATP1B3 [2]
OATP1B3 Transporter Info Km = 3.4 microM Human embryonic kidney cells (HEK293)-OATP1B3 [3]
OATP2B1 Transporter Info Km = 1.09 microM Human embryonic kidney cells (HEK293)-OATP2B1 [3]
References
1 Telmisartan was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans. Drug Metab Dispos. 2006 Jul;34(7):1109-15.
3 Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Drug Metab Dispos. 2008 Apr;36(4):796-805.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.